3 | DNA (Deoxyribonucleic Acid)IBA
03/2023
-
08/2016 |
3 | TriterpenesIBA
01/2023
-
05/2006 |
3 | Hydrogen Sulfide (Sulfide, Hydrogen)IBA
05/2021
-
01/2020 |
3 | oridoninIBA
01/2020
-
01/2016 |
2 | sinomenineIBA
01/2024
-
12/2022 |
2 | AcidsIBA
01/2024
-
11/2017 |
2 | Brefeldin AIBA
05/2023
-
01/2023 |
2 | Mechlorethamine (Nitrogen Mustard)FDA Link
12/2022
-
01/2021 |
2 | Carbolines (Beta-Carbolines)IBA
01/2021
-
01/2021 |
1 | evodiamineIBA
01/2024 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2024 |
1 | octanoic acid (caprylic acid)IBA
01/2024 |
1 | Dosage Forms (Dosage Form)IBA
01/2024 |
1 | isothiocyanic acidIBA
05/2023 |
1 | fascaplysineIBA
03/2023 |
1 | AlkaloidsIBA
03/2023 |
1 | 5- (4- hydroxyphenyl)- 3H- 1,2- dithiole- 3- thioneIBA
01/2023 |
1 | ChromonesIBA
12/2022 |
1 | Antihypertensive Agents (Antihypertensives)IBA
12/2021 |
1 | NitroreductasesIBA
09/2021 |
1 | Immunoconjugates (Immunoconjugate)IBA
06/2021 |
1 | SilverIBA
05/2021 |
1 | Therapeutic UsesIBA
05/2021 |
1 | SincalideFDA Link
01/2021 |
1 | 1,2,5-oxadiazole 2-oxideIBA
01/2021 |
1 | Carbon MonoxideIBA
02/2020 |
1 | GasotransmittersIBA
02/2020 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2020 |
1 | HAO472IBA
01/2020 |
1 | chelidonineIBA
01/2020 |
1 | EstersIBA
06/2019 |
1 | Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
12/2018 |
1 | Cytochromes c (Cytochrome c)IBA
02/2018 |
1 | enmeinIBA
02/2018 |
1 | DiterpenesIBA
02/2018 |
1 | Caspase 3 (Caspase-3)IBA
02/2018 |
1 | DAPIIBA
11/2017 |
1 | Annexin A5IBA
11/2017 |
1 | 5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
11/2017 |
1 | Fluorouracil (Carac)FDA LinkGeneric
11/2017 |
1 | Antineoplastic Agents (Antineoplastics)IBA
07/2017 |
1 | scutellarinIBA
07/2017 |
1 | RNA (Ribonucleic Acid)IBA
08/2016 |
1 | Proteins (Proteins, Gene)FDA Link
08/2016 |
1 | Antimutagenic Agents (Antimutagens)IBA
08/2016 |
1 | XanthonesIBA
01/2012 |
1 | Death Domain ReceptorsIBA
02/2008 |
1 | boswellic acidIBA
02/2008 |